116 related articles for article (PubMed ID: 24789372)
21. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
[TBL] [Abstract][Full Text] [Related]
22. Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration in Shetland ponies sedated with xylazine.
Larenza MP; Knobloch M; Landoni MF; Levionnois OL; Kronen PW; Theurillat R; Schatzmann U; Thormann W
Vet J; 2008 Sep; 177(3):432-5. PubMed ID: 17604192
[TBL] [Abstract][Full Text] [Related]
23. Role of the equine CYP3A94, CYP3A95 and CYP3A97 in ketamine metabolism in presence of medetomidine, diazepam and methadone studied by enantioselective capillary electrophoresis.
Sandbaumhüter FA; Vimercati S; Thormann W; Mevissen M
Toxicol In Vitro; 2018 Aug; 50():242-248. PubMed ID: 29614330
[TBL] [Abstract][Full Text] [Related]
24. [Determination of ketamine and norketamine in blood and urine by high performance liquid chromatography].
Chen LL; Lia OL; Li WJ; Huang LY; Yan YY; Yang L; Ma XN; He R
Fa Yi Xue Za Zhi; 2008 Feb; 24(1):38-42. PubMed ID: 18404991
[TBL] [Abstract][Full Text] [Related]
25. Antinociceptive effects, metabolism and disposition of ketamine in ponies under target-controlled drug infusion.
Knobloch M; Portier CJ; Levionnois OL; Theurillat R; Thormann W; Spadavecchia C; Mevissen M
Toxicol Appl Pharmacol; 2006 Nov; 216(3):373-86. PubMed ID: 16919695
[TBL] [Abstract][Full Text] [Related]
26. Stereoselective high-performance liquid chromatographic determination of the enantiomers of ketamine and norketamine in plasma.
Geisslinger G; Menzel-Soglowek S; Kamp HD; Brune K
J Chromatogr; 1991 Jul; 568(1):165-76. PubMed ID: 1770094
[TBL] [Abstract][Full Text] [Related]
27. Effect of the α
Sandbaumhüter FA; Theurillat R; Bettschart-Wolfensberger R; Thormann W
Electrophoresis; 2017 Aug; 38(15):1895-1904. PubMed ID: 28251651
[TBL] [Abstract][Full Text] [Related]
28. Determination of ketamine and norketamine in plasma by micro-liquid chromatography-mass spectrometry.
Legrand T; Roy S; Monchaud C; Grondin C; Duval M; Jacqz-Aigrain E
J Pharm Biomed Anal; 2008 Sep; 48(1):171-6. PubMed ID: 18584989
[TBL] [Abstract][Full Text] [Related]
29. Electrophoretically mediated microanalysis for characterization of the enantioselective CYP3A4 catalyzed N-demethylation of ketamine.
Ying Kwan H; Thormann W
Electrophoresis; 2012 Nov; 33(22):3299-305. PubMed ID: 22949220
[TBL] [Abstract][Full Text] [Related]
30. Stereoselective biotransformation of ketamine in equine liver and lung microsomes.
Schmitz A; Portier CJ; Thormann W; Theurillat R; Mevissen M
J Vet Pharmacol Ther; 2008 Oct; 31(5):446-55. PubMed ID: 19000264
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of carbon-14 labeled ketamine and norketamine.
Chen L; Gong Y; Salter R
J Labelled Comp Radiopharm; 2018 Sep; 61(11):864-868. PubMed ID: 29992626
[TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of differences in phase 1 metabolism of ketamine and other analgesics among humans, horses, and dogs.
Capponi L; Schmitz A; Thormann W; Theurillat R; Mevissen M
Am J Vet Res; 2009 Jun; 70(6):777-86. PubMed ID: 19496669
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of ketamine and its major metabolites norketamine, hydroxynorketamine, and dehydronorketamine: a model-based analysis.
Kamp J; Jonkman K; van Velzen M; Aarts L; Niesters M; Dahan A; Olofsen E
Br J Anaesth; 2020 Nov; 125(5):750-761. PubMed ID: 32838982
[TBL] [Abstract][Full Text] [Related]
34. Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers.
Yanagihara Y; Ohtani M; Kariya S; Uchino K; Hiraishi T; Ashizawa N; Aoyama T; Yamamura Y; Yamada Y; Iga T
Biopharm Drug Dispos; 2003 Jan; 24(1):37-43. PubMed ID: 12516077
[TBL] [Abstract][Full Text] [Related]
35. Ketamine and norketamine stability in whole blood at ambient and 4°C conditions.
Tran BD; Moorthy GS; Zuppa AF
Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 28976571
[TBL] [Abstract][Full Text] [Related]
36. The effect of route of administration on the enantioselective pharmacokinetics of ketamine and norketamine in rats.
Le Nedelec M; Glue P; Winter H; Goulton C; Medlicott NJ
J Psychopharmacol; 2018 Oct; 32(10):1127-1132. PubMed ID: 29895202
[TBL] [Abstract][Full Text] [Related]
37. Determination of ketamine and norketamine enantiomers in plasma by solid-phase extraction and high-performance liquid chromatography.
Svensson JO; Gustafsson LL
J Chromatogr B Biomed Appl; 1996 Apr; 678(2):373-6. PubMed ID: 8738047
[TBL] [Abstract][Full Text] [Related]
38. Equine cytochrome P450 2B6--genomic identification, expression and functional characterization with ketamine.
Peters LM; Demmel S; Pusch G; Buters JT; Thormann W; Zielinski J; Leeb T; Mevissen M; Schmitz A
Toxicol Appl Pharmacol; 2013 Jan; 266(1):101-8. PubMed ID: 23142468
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of ketamine and its metabolite, norketamine, after intravenous administration of a bolus of ketamine to isoflurane-anesthetized dogs.
Pypendop BH; Ilkiw JE
Am J Vet Res; 2005 Dec; 66(12):2034-8. PubMed ID: 16379643
[TBL] [Abstract][Full Text] [Related]
40. Interaction between morphine and norketamine enantiomers in rodent models of nociception.
Holtman JR; Crooks PA; Johnson-Hardy J; Wala EP
Pharmacol Biochem Behav; 2008 Oct; 90(4):769-77. PubMed ID: 18582492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
